SpectraWAVE, Inc. logo — Improving coronary artery disease outcomes with optical and...

SpectraWAVE, Inc.

Improving coronary artery disease outcomes with optical and computational insights.

Founded 2017 United States Bedford, United States 56 employees Series B Biotechnology, Health Care +1

General Information

Company Name SpectraWAVE, Inc.
Founded Year 2017
Location United States Bedford, United States +1
Employees 56
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when SpectraWAVE, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SpectraWAVE, Inc.

SpectraWAVE, located in Bedford, Mass., is a privately held medical device company founded in 2017 to provide unrivaled optical and computational insights to improve the treatment and outcomes for patients with coronary artery disease (CAD). CAD, the buildup of plaque in the wall of the arteries that supply blood to the heart, affects 18.2 million adults age 20 and older. In CAD patients that undergo percutaneous stent placement, it is estimated that one in five patients experience adverse events within two years. SpectraWAVE’s state of the art HyperVue™ Imaging System combines next generation DeepOCT™ images and near infrared spectroscopy (NIRS) with workflows optimized for the cardiac catheterization lab. The HyperVue Imaging System is intended for the imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. The NIRS capability of the system is intended for the identification of patients and plaques at increased risk of major adverse cardiac events. For more information and complete indications for use, please visit www.spectrawave.com.

Taxonomy: medical device development, cardiovascular disease, optical and computational technology, coronary artery disease, DeepOCT, near infrared spectroscopy, diagnostic equipment, therapeutic devices, interventional cardiology, cardiac catheterization, patient outcomes, transluminal interventional procedures

No funding data available for SpectraWAVE, Inc. yet.

Get notified when SpectraWAVE, Inc. raises funding

SpectraWAVE, Inc. Alternatives & Competitors

SpectraWAVE, Inc. vs

Committed to comprehensive heart and vascular care with advanced diagnostic and interventional proce...

41 employees
Health Care
SpectraWAVE, Inc. vs
Kaminari Medical
Kaminari Medical The Netherlands

Combining ultrasound and optical imaging to revolutionize coronary revascularization

Seed
7 employees
Health Care, Medical Devices
SpectraWAVE, Inc. vs
PlaqueTec Ltd.
PlaqueTec Ltd. United Kingdom

Opening a new frontier in the fight against atherosclerosis

Series Unknown
5 employees
Health Care
Also compare with: SpectraWAVE, Inc. vs CathWorks CathWorks

FAQ About SpectraWAVE, Inc.

Improving coronary artery disease outcomes with optical and computational insights.
SpectraWAVE, Inc. was founded in 2017.
SpectraWAVE, Inc. is headquartered in Bedford, United States.
SpectraWAVE, Inc. operates in the following industries: Biotechnology, Health Care, Medical Devices.
SpectraWAVE, Inc. has approximately 56 employees.
Top alternatives and competitors to SpectraWAVE, Inc. include Cardiology Partners, Kaminari Medical, PlaqueTec Ltd., CathWorks, Life Flow. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SpectraWAVE, Inc. and Cardiology Partners are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SpectraWAVE, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy